Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/31205
Title: Primary percutaneous coronary intervention for acute myocardial infarction caused by unprotected left main stem thrombosis.
Authors: Malaiapan Y.;MacIsaac A.;Meredith I.T. ;Ahmar W.;Prasad S.B.;Whitbourn R.
Institution: (Prasad, Malaiapan, Ahmar, Meredith) MonashHeart, Monash Medical Centre, 246 Clayton Road, Melbourne, VIC 3168, Australia (Whitbourn, MacIsaac) St Vincents' Hospital, Victoria Parade, Melbourne, VIC, Australia
Issue Date: 14-Oct-2012
Copyright year: 2009
Publisher: Wiley-Liss Inc. (111 River Street, Hoboken NJ 07030-5774, United States)
Place of publication: United States
Publication information: Catheterization and Cardiovascular Interventions. 73 (3) (pp 301-307), 2009. Date of Publication: 15 Feb 2009.
Abstract: Background: There is a paucity of data on outcomes in patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) caused by left main stem (LMS) thrombosis. Objective(s): We sought to determine (i) the clinical features, (ii) correlates of early mortality, and (iii) long-term outcomes in contemporary patients undergoing primary PCI for unprotected LMS thrombosis. Method(s): From 1,115 consecutive primary PCI cases at two tertiary referral centers between January 2004 and September 2007, 28 cases (2.5%) with unprotected LMS culprit lesions were identified. Data were obtained from review of institutional databases, folder audit, telephone survey of patients, and independent review of angiograms. Result(s): The mean age of patients was 68 +/- 14 years. Males comprised 76%, and 21% had diabetes. Significant morbidity was noted at presentation: shock in 18 (62%), pulmonary oedema in 15 (52%), and cardiac arrest in 10 (35%) patients, respectively. Lesion location was ostial in 7 (25%), body in 8 (29%), and distal in 13 (46%) patients, respectively. Angiographic success was achieved in 24 patients (83%). Stents were deployed in 27 patients (96%); drug-eluting stents in 11 patients (39%). No patient required in-hospital CABG. Cumulative in-hospital mortality was 36%. Univariate predictors of in-hospital mortality included shock, preceding cardiac arrest, and angiographic failure (all P < 0.05). At a mean follow-up of 26 +/- 12 months in hospital survivors, there were two TVR (elective CABGs), one death, and no reinfarctions. Conclusion(s): We report a lower than previously reported in-hospital mortality of 36% in contemporary patients undergoing primary PCI for unprotected LMS thrombosis. Long-term outcomes in hospital survivors appear favorable. © 2009 Wiley-Liss, Inc.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/ccd.21886
PubMed URL: 19213083 [http://www.ncbi.nlm.nih.gov/pubmed/?term=19213083]
ISSN: 1522-1946
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/31205
Type: Article
Subjects: major clinical study
male
morbidity
mortality
*percutaneous coronary intervention
prognosis
shock
survivor
treatment response
causal attribution
*acute heart infarction/co [Complication]
*acute heart infarction/th [Therapy]
aged
angiocardiography
article
cause of death
clinical feature
coronary artery bypass surgery
*coronary artery thrombosis
diabetes mellitus
drug eluting stent
female
heart arrest
heart reinfarction/co [Complication]
human
*left coronary artery
long term care
lung edema
female
heart arrest
heart reinfarction / complication
human
*left coronary artery
long term care
lung edema
major clinical study
male
morbidity
mortality
*percutaneous coronary intervention
prognosis
shock
survivor
treatment response
angiocardiography
*acute heart infarction / *complication / *therapy
aged
article
causal attribution
cause of death
clinical feature
coronary artery bypass surgery
*coronary artery thrombosis
diabetes mellitus
drug eluting stent
Appears in Collections:Articles

Show full item record

Page view(s)

16
checked on Jun 17, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.